{"name":"Zhongmou Therapeutics","slug":"zhongmou-therapeutics","ticker":"","exchange":"","domain":"zhongmou.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxNNzg2TG1VWW1CdXdkQUFuUzRVd0JGQ0x0OEMyQ2p6OWh1QjRnXy1fUXQzTFJyRkpWdEVaZ0t6R21qelJjVEpjRzdTMnU1S0M4dVphZ1o1aGhiVEx6ams2QjFVQ1ROSkV0RkwtU1c0SjVDZUJoZ1JLczFveEhXekxHOGtadF9IR193bVhMVFhiSThlNk9TaFl2TVYzcVA1ajFMbjFqbDRmTkJnMXVKUmh0YldiZVh6QkVWSnM3QUpCTmhYdEh3c3RMS2NlOWo4NzNQMkhaVmp6Q0Vmdnp6OUNsT2hONWh4ek5ZZDRIdWFXeDJKbm5kbjlNY05lMnhyTzRGRkRaeXlFZFM4MUtVbmg1M1BKWFc?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"AAV Vectors in Gene Therapy Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"AAV Vectors in Gene Therapy Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Ma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQOUZKcVVVMlQ1N0licFpwTmQ2YUlvczVtQlFvNjRmZmY5NDhXMDZHbkhNNm1HV2FnYTA0Y0IzZ0lFb0dLNE11WHI2Qzd5T3pjMm44SVA5bjkwVWRPcE1WdTJQQ0xUODh5Mml6ajB5a09iMU8teTk0SW45WGpnMnZYRldFd211STM2NTlUOVBPb2ZqdG5QRHFqWm1JelB0SFhMWlJoVVlVRHJXR1gycW5PRFEyQmdWcEZOT0x6dnRR?oc=5","date":"2025-12-04","type":"regulatory","source":"Eyes On Eyecare","summary":"FDA clears Zhongmou Therapeutics' IND for RP optogenetic gene therapy - Eyes On Eyecare","headline":"FDA clears Zhongmou Therapeutics' IND for RP optogenetic gene therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQOTY4SnZWdW82U3NKdERDSUVMODZ0ZExrT054V3UtT1MyRVpwUjg4a2VXRERKMDNnZXF3WkpMOWIxLVZ2dmFrSEhnUFR6RWs0cHRlUVY5dTZOSlpXWXl5eVdtMm1oZ0l2b1laTkdpSzE1OTVjRUV4cDRvcHl2RFNuYV9CZlRiNjVvMUVDNHVtLU5ZMkVFcFdsVEM2YnNjZm1oczc5MVZsVG9Zd0U?oc=5","date":"2025-11-28","type":"trial","source":"The Pharma Letter","summary":"New Chinese milestone as Zhongmou wins US clearance for trials - The Pharma Letter","headline":"New Chinese milestone as Zhongmou wins US clearance for trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5DT2s4Q2M0NVhYeWJPN01QRkZSeXl4aWhsenpzanRMV3NDX1pISDdtSm5PczI3RWszejNzU2otRVhmNWdUYlBmTU5GQndGczJRLV80?oc=5","date":"2025-11-27","type":"pipeline","source":"FirstWord Pharma","summary":"Zhongmou says its optogenetic gene therapy helps retinitis pigmentosa patients see again - FirstWord Pharma","headline":"Zhongmou says its optogenetic gene therapy helps retinitis pigmentosa patients see again","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQa2ZuaGNoVDVOa1Fuenk2SElzV3ZQY0ZONGhjc2xCVHp0TDBHblBEM1o1dHVaVEFWQVd2a0t5bUw3LURhTDlkNlh4dFQxYXcwa2VEOEo1bGFCN2JxNGpLdS1vQWxmS0FyTWxKYXZnNDNDLXMtZnd2T0h1dWtVTm8wb3EtOVV1QnJhUWw4MHJKcnRmUDFZTFJiOFNkVTFJZHVsQXM0YmFUdjFWQkp4Um02WWxKVi0xc1Va?oc=5","date":"2025-11-27","type":"trial","source":"Clinical Trials Arena","summary":"Zhongmou Therapeutics’ RP gene therapy shows promise in first-in-human trial - Clinical Trials Arena","headline":"Zhongmou Therapeutics’ RP gene therapy shows promise in first-in-human trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNcklvaWFpYkN0bjNvZlliTk1ZR3hDTFdfLTQ2dXh5ZDRaUXRCXzFRcm5SUHdhWmdBSGhpZ1MzeGhadnlkbHh1UmZnQnRFZ2tTMV9NNkNEN1BlUTNNWnE0RlNUWFhkckhXcWFLSExnNjE1dDdUT1RVOFJSdnIxOHVRUmZZbzZoYjRYODZzelZPOHJrX3ZoQkNQTQ?oc=5","date":"2025-11-26","type":"trial","source":"endpoints.news","summary":"China biotech seeks to rewire eye cells to create ‘one-size-fits-all’ rival to Luxturna - endpoints.news","headline":"China biotech seeks to rewire eye cells to create ‘one-size-fits-all’ rival to Luxturna","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPMVZNZFctM3MzeWxZU1JpSXRmQW9hX1hSbWZUTzU3QmNGQ0tsN0hfa05ER1dTNS1OMzlYd2RyaGFYdU5wMjF5UEhvY1hyakJSNTJTSjZYWXZsRWlmeFlKNXNHWWloVGd2eDJ3bmFBRUZMY0hyX0FNcGRKZjZYdXZsUmRhYVZQbEp0UzQ5ekpEUUN3S29TTTZSMHdoYUdCNlc1LV9vN2JQYVFBNDgzSk9pTVFn?oc=5","date":"2025-11-21","type":"deal","source":"Drug Discovery News","summary":"Lilly strengthens gene therapy portfolio with MeiraGTx and Adverum deals - Drug Discovery News","headline":"Lilly strengthens gene therapy portfolio with MeiraGTx and Adverum deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQdjA4NjRPMVVoaVhDdmI1M2tpb0pyWlNpd3hTLVRNT01zNXVJc3NPQUpnUUEyV1pqZWNUN2lXdFdDX3dkcUNuTklNWU9NMzNQWGFXcGtRNF94QW5BTkhnYTBqN25OTmpBUVB4YXZTalg5UnN3TkNKZTdqa0ZyM2Njc21EX1MtQ0F6Y19pVHlNeXM0R21OV3dKaU01aHNOSzRBcV9CWWlmNFlHS25hQ3R5S1VKRjQyRmZWOWE2UHNRclJEakY4X1ZLekEtNmViMkFpclRzaldDT1RVaHBoanhNbUJBVG41NUxtTE1XUGxfa3JaZXQwUW54enQ1cFN3NmtwUTJHUlR0c0tHWHRLTDFKSlNuSnlEaUNRa2JqYXk5aGZKQTdOaTk0YTVyUnpKaHRiNDQwNmJkUFFJS2dhckhpN3BxNVkzRjg?oc=5","date":"2025-11-17","type":"pipeline","source":"GlobeNewswire","summary":"Dry Age-related Macular Degeneration Market Poised for - GlobeNewswire","headline":"Dry Age-related Macular Degeneration Market Poised for","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}